3,688
edits
Obesity: Difference between revisions
no edit summary
No edit summary |
No edit summary |
||
| Line 39: | Line 39: | ||
Weghuber D, Barrett T, Barrientos-Pérez M, et al. Once-Weekly Semaglutide in Adolescents with Obesity. The New England journal of medicine. Dec 15 2022;387(24):2245-2257. doi:10.1056/NEJMoa2208601 | Weghuber D, Barrett T, Barrientos-Pérez M, et al. Once-Weekly Semaglutide in Adolescents with Obesity. The New England journal of medicine. Dec 15 2022;387(24):2245-2257. doi:10.1056/NEJMoa2208601 | ||
[https://pubmed.ncbi.nlm.nih.gov/35441470/ STEP 1 Study Group. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension] | |||
[https://pubmed.ncbi.nlm.nih.gov/24708463/ A retrospective description of anesthetic medication dosing in overweight and obese children] | [https://pubmed.ncbi.nlm.nih.gov/24708463/ A retrospective description of anesthetic medication dosing in overweight and obese children] | ||